Knowledge level of cardio-oncology in oncologist and cardiologist: a survey in China

Author:

Liu Binliang12,Wang Yanfeng3,An Tao4,Cheng Leilei5,Liu Ying6,Ou Jianghua7,Li Hong8,Zhao Xuemei4,Xia Yunlong6,Zhang Yuhui4,Ma Fei1

Affiliation:

1. Department of Medical Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

2. Department of Breast Cancer Medical Oncology, Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya Medical School, Central South University, Changsha, Hunan 410013, China

3. Department of Comprehensive Oncology, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China

4. State Key Laboratory of Cardiovascular Disease, Heart Failure Center, Fuwai Hospital, National Center for Cardiovascular Disease, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100037, China

5. Department of Echocardiography, Zhongshan Hospital, Fudan University, Shanghai 200032, China

6. Department of Cardiology, The First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning 116011, China

7. Second Breast Surgery, Xinjiang Cancer Hospital, Xinjiang Medical University, Urumqi, Xinjiang 830011, China

8. Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine,General Medicine

Reference6 articles.

1. Cancer statistics in China and United States, 2022: profiles, trends, and determinants;Xia;Chin Med J,2022

2. 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines;Zamorano;Eur Heart J,2016

3. Working together to advance cardio-oncology in China;Xia;JACC,2020

4. Cardio-oncology in China: we are on the Go!;Zhang;JACC,2020

5. Onco-cardiology: the time has come;Yeh;Tex Heart Inst J,2011

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3